These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6136644)

  • 21. Visceral leshmaniasis diagnosed on duodenal biopsy in a child.
    Boukthir S; Mejri A; M'rad S; Barsaoui S
    Acta Gastroenterol Belg; 2003; 66(3):258-9. PubMed ID: 14618961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar.
    Giri OP; Singh AN
    J Assoc Physicians India; 1994 Sep; 42(9):690-1. PubMed ID: 7883660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
    Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
    [No Abstract]   [Full Text] [Related]  

  • 24. Echocardiographic evaluation of cardiac status in Indian visceral leishmaniasis patients.
    Shrivastava R; Sinha PR; Singh VP; Sundar S
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):429-32. PubMed ID: 17049574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Salih MAM; Fakiola M; Lyons PA; Younis BM; Musa AM; Elhassan AM; Anderson D; Syn G; Ibrahim ME; Blackwell JM; Mohamed HS
    Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of visceral leishmaniasis].
    Popov G; Andreeva N; Georgiev A; Kuzmanova E
    Vutr Boles; 1991; 30(2):121-5. PubMed ID: 1654012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?
    Hamerlinck FF; van Gool T; Faber WR; Kager PA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):31-4. PubMed ID: 10617787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine structure of Leishmania donovani in bone marrow aspirates from a patient with visceral leishmaniasis before and during treatment with sodium stibogluconate.
    el-Shoura SM; Sheikha AK
    Trop Med Parasitol; 1991 Jun; 42(2):119-26. PubMed ID: 1654589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial villous atrophy in nutritional megaloblastic anaemia corrected by folic acid therapy.
    Dawson DW
    J Clin Pathol; 1971 Mar; 24(2):131-5. PubMed ID: 5551380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis (kala-azar) as a cause of fever of unknown origin.
    Geraci JE; Wilson WR; Thompson JH
    Mayo Clin Proc; 1980 Jul; 55(7):455-8. PubMed ID: 6247584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal absorptive and digestive function in pernicious anemia.
    Arvantakis C; Lyford CL; Folscroft J
    Am J Med; 1977 Dec; 63(6):859-64. PubMed ID: 605906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption of d-xylose and fat and histological changes of the small intestine in patients after partial gastrectomy.
    Beno I; Bucko A; Chorváthová V; Babala J
    Digestion; 1970; 3(2):97-104. PubMed ID: 5423318
    [No Abstract]   [Full Text] [Related]  

  • 35. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis and malabsorption.
    Gupta JK; Ingegno AP; Cook AW; Pertschuk LP
    Am J Gastroenterol; 1977 Dec; 68(6):560-5. PubMed ID: 612212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 38. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of kala-azar in north India.
    Aggarwal P; Wali JP
    Asia Pac J Public Health; 1991; 5(1):90-3. PubMed ID: 1665981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.